Regulatory Issues

FDA Policy Seeks to Increase Number of Generics on Market

FDA Policy Seeks to Increase Number of Generics on Market

By

The FDA has announced a new policy to expedite reviews of generic drug applications in cases where competition is limited.

Cannabis for Medicine: Research and Policies Needed

Cannabis for Medicine: Research and Policies Needed

By

Medical marijuana, as a botanical and a scheduled drug does not fit the FDA paradigm for drug approval, a major impediment to its use in research.

Sign Up for Free e-Newsletters